EGF and ovarian cancer: Using breast, pancreatic, and ovarian cancer cells, transforming growth factor beta-1 (TGFB1) or epidermal growth factor (EGF) treatment or SNAI1 overexpression increased stemness and reduced let-7 expression, while SNAI1 knockdown reduced stemness and increased let-7 expression.